Cite
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
MLA
Leotta, Salvatore, et al. “The Role of Ponatinib in Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia after Allogeneic Transplantation: A Real-Life Retrospective Multicenter Study.” Annals of Hematology, vol. 100, no. 7, July 2021, pp. 1743–53. EBSCOhost, https://doi.org/10.1007/s00277-021-04504-0.
APA
Leotta, S., Markovic, U., Pirosa, M. C., Stella, S., Tringali, S., Martino, M., Specchia, G., Carluccio, P., Risitano, A. M., Grimaldi, F., Vigna, E., Palmieri, F., Palmieri, R., Annunziata, M., Pisapia, G., Palazzo, G., Milone, G. A., Pelle, A. C., Scalise, L., & Di Giorgio, M. A. (2021). The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study. Annals of Hematology, 100(7), 1743–1753. https://doi.org/10.1007/s00277-021-04504-0
Chicago
Leotta, Salvatore, Uros Markovic, Maria Cristina Pirosa, Stefania Stella, Stefania Tringali, Massimo Martino, Giorgina Specchia, et al. 2021. “The Role of Ponatinib in Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia after Allogeneic Transplantation: A Real-Life Retrospective Multicenter Study.” Annals of Hematology 100 (7): 1743–53. doi:10.1007/s00277-021-04504-0.